Self-Test Strategies and Linkage Incentives to Improve ART and PrEP Uptake in Men

Not Applicable

Completed

• Conditions: Acquired Immunodeficiency Syndrome; Virus Diseases; Sexually Transmitted Diseases, Viral; Retroviridae Infections; Human Immunodeficiency Virus; HIV Infections; RNA Virus Infections; Virus-HIV
• Interventions: Behavioral: Provision of multiple self-tests; Other: Small monetary incentives; Behavioral: Use of SMS/text reminders to motivate adherence to ART or PrEP

• Registration Number: NCT04772469
• Lead Sponsor: University of California, San Francisco

Brief Summary

This is a randomized controlled trial to test a combination behavioral and biomedical interventions to improve the HIV prevention and care cascades in a population of mobile men in a high priority setting (fishermen in Kenya). The intervention strategy is to recruit and train highly socially-connected men to distribute HIV self-tests and provide linkage support to men in their close social networks. The study will determine whether this social network-based approach along with small financial incentives in the form of transport vouchers can increase men's self-testing, linkage to and uptake of ART and PrEP after self-testing, virologic suppression at 6 months (for those initiating ART) and PrEP adherence (for those initiating PrEP) at 6 months. The study includes a longitudinal qualitative and mixed methods (quantitative and qualitative assessments) to identify the pathways of intervention action, and understand how the social network-based approach with support for linkage affects testing and ART and PrEP uptake and retention in men.

Detailed Description

In Aim 1, following the study pilot, community selection, and preparation the investigators will conduct a census/BMU registry verification in study communities to identify the population of men eligible for the study. The study will screen, recruit and enroll eligible men who give their informed consent to participate, then measure their close social networks identify network-central, highly-connected men ("promoters") and randomize their close social network (a cluster) to 1:1 intervention and control groups. Investigators will then conduct a baseline survey to collect socio demographic and baseline sexual behavior data among men in the close social networks. Following this baseline data collection, all promoters will be provided a training. Promoters in the intervention group will receive HIVST training, multiple HIVST for distribution to other men, and a small amount of remuneration. Promoters in the control group will receive basic HIV education and training about the study, and will be given vouchers that can be exchanged for HIV tests (standard or free HIVST kits) at nearby health facilities. Using follow-up survey data, investigators will test the hypothesis that a higher rate of HIV testing will be observed after 3 months among men in networks that receive the intervention compared to control.

In Aim 2, investigators will test whether network-central promoters can enhance linkage to ART and PrEP after HIV testing among men in their close social networks. Promoters in the Aim 1 intervention group will be asked to distribute information and transport vouchers for ART or PrEP when distributing HIV self-tests to men in their close social networks. Investigators will use clinic data to test the primary hypothesis that the intervention will result in higher rates of linkage to ART or PrEP (confirmatory testing and ART referral for positives, and PrEP screening for negatives). Investigators also will test the hypothesis that higher ART and PrEP uptake will be observed within 3 months (+ about one month) in the intervention group.

In Aim 3, investigators will measure 6 month VL and 6 month tenofovir levels using viral load testing and a novel point of care PrEP adherence assay (an antibody-based assay permitting measurement of tenofovir levels in urine) in study sites, and test the hypothesis that higher rates of virologic suppression will be observed in HIV-infected men, and PrEP adherence in un-infected men, in the intervention group. Viral load measurements will be conducted by drawing additional venous blood during routine blood draws scheduled for MOH viral load monitoring (as well as additional draws during scheduled appointments for those occurring outside of the annual VL testing standard of care window). PrEP adherence will be measured utilizing the study urine assay at 6 months. HIV treatment adherence will measured through adherence assessment during 3 and 6 routine clinic visits.

Across all aims, investigators will assess the pathways of intervention action using qualitative and mixed methods. Investigators will identify the mechanisms of action, and barriers and facilitators of the social network and incentives intervention implementation, using qualitative and mixed methods quantitative and qualitative assessments embedded in Aims 1, 2 and 3. The data collection approach will include in-depth interviews with participants in both groups, key informant interviews with network-central promoters, and focus group discussions with study participants stratified by HIV status and study group. Data will be collected at baseline and three follow-up periods corresponding to the timing of quantitative outcome measurements in Aims 1 through 3.

Basic Information
|
Recruitment & Eligibility
|
Study & Design
|
Trial Locations

Study Timeline

• Study First Submitted: 2021-02-23
• Study First Submitted QC: 2021-02-23
• Study First Posted: 2021-02-26
• Study Start: 2021-03-22
• Primary Completion: 2023-04-26
• Study Completion: 2023-04-26
• Status Verified: 2023-08
• Last Update Submitted: 2023-08-09
• Last Update Posted: 2023-08-14

Recruitment & Eligibility

• Status: COMPLETED
• Sex: Male
• Target Recruitment: 1509

Inclusion Criteria

• Adult (18 years or older)
• Male
• Working as a fisherman or fishing-related occupation
• Willing and able to provide informed consent for participation
• Not participating in another research study related to HIV testing, treatment and/or prevention

Read More

Exclusion Criteria

• Younger than 18 years of age
• Female
• Included in another intervention study on HIV/AIDS
• Inadequate cognitive and/or hearing capacity to complete planned study procedures, at the discretion of the study team

Read More

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Promoter training, multiple self-test kits, and incentives	Provision of multiple self-tests	Promoters in the intervention group will receive HIVST training, multiple HIVST for distribution to other men, and a small amount of remuneration (transport voucher) for themselves and to distribute to men in their networks.
Promoter training, multiple self-test kits, and incentives	Small monetary incentives	Promoters in the intervention group will receive HIVST training, multiple HIVST for distribution to other men, and a small amount of remuneration (transport voucher) for themselves and to distribute to men in their networks.
Promoter training, multiple self-test kits, and incentives	Use of SMS/text reminders to motivate adherence to ART or PrEP	Promoters in the intervention group will receive HIVST training, multiple HIVST for distribution to other men, and a small amount of remuneration (transport voucher) for themselves and to distribute to men in their networks.

Primary Outcome Measures

Name	Time	Method
Linkage to care or prevention	Up to 3 months	For HIV-positive participants (care): the proportion of participants who obtained confirmatory HIV testing (yes/no), 3-months following self-reported HIV testing AND the proportion of participants who had an HIV clinic visit (yes/no), 3-months following confirmatory HIV testing.; For HIV-negative participants (prevention): the proportion of participants who obtained confirmatory HIV testing (yes/no) 3-months following self-reported testing AND the proportion of participants who were evaluated for PrEP (yes/no), 3-months following confirmatory HIV testing.
Self-reported HIV testing	Up to 3 months	Proportion of participants who self-report HIV testing (yes/no) within the past 3 months, measured at 3-month follow-up.

Secondary Outcome Measures

Name	Time	Method
Linkage to ART or to PrEP	Up to 3 months	ART: Proportion of HIV-positive participants who initiate ART prescription (yes/no), 3-months following confirmatory testing and eligibility screening.; PrEP: Proportion of PrEP-eligible HIV-negative participants who initiate PrEP prescription (yes/no), 3-months following confirmatory testing and eligibility screening.
HIV testing after 3 months	3 to 6 months	Confirmatory HIV testing uptake 3 to 6 months after intervention start
Adherence to ART or PrEP	Up to 6 months	ART: Proportion of HIV-positive participants who attain viral suppression (HIV RNA \<400 c/mL), 6 months following ART initiation.; PrEP: proportion of PrEP-taking HIV-negative participants who are adherent to PrEP (TFV levels of \>= 1500 ng/mL) at 6 months following PrEP initiation.

Trial Locations

Locations (1)

Impact Research Development Organization; 🇰🇪 Siaya, Kenya